High-density lipoprotein particle number: A better measure to quantify high-density lipoprotein?

Journal of the American College of Cardiology

Volumn 60, Issue 6, 2012, Pages 517-520

  Degoma, Emil M ^a   Rader, Daniel J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

coronary heart disease; high density lipoprotein cholesterol; high density lipoprotein particles; lipids; lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN PARTICLE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN PARTICLE; NICOTINIC ACID; PLACEBO; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ARTERIAL WALL THICKNESS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE MARKER; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; RELIABILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 84864756191     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.058     Document Type: Editorial

References (18)

1. M.J. McQueen, S. Hawken, X. Wang Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study Lancet 372 2008 224 233
2. T. Pischon, C.J. Girman, F.M. Sacks, N. Rifai, M.J. Stampfer, E.B. Rimm Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men Circulation 112 2005 3375 3383
3. M. Benn, B.G. Nordestgaard, G.B. Jensen, A. Tybjaerg-Hansen Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study Arterioscler Thromb Vasc Biol 27 2007 661 670
4. E.J. Jeyarajah, W.C. Cromwell, J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870
5. W.C. Cromwell, J.D. Otvos, M.J. Keyes LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study - implications for LDL management J Clin Lipidol 1 2007 583 592
6. K. El Harchaoui, B.J. Arsenault, R. Franssen High-density lipoprotein particle size and concentration and coronary risk Ann Intern Med 150 2009 84 93
7. R.H. Mackey, P. Greenland, D.C. Goff Jr, D. Lloyd-Jones, C.T. Sibley, S. Mora High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 60 2012 508 516
8. S. Mora, J.E. Buring, P.M. Ridker, Y. Cui Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study Ann Intern Med 155 2011 742 750
9. B. Lamarche, S. Moorjani, P.J. Lupien Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study Circulation 94 1996 273 278
10. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, E. Steiner High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2001 2026 2033
11. A. Kontush, M.J. Chapman Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis Pharmacol Rev 58 2006 342 374
12. W.A. van der Steeg, I. Holme, S.M. Boekholdt High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies J Am Coll Cardiol 51 2008 634 642
13. A.V. Khera, M. Cuchel, M. de la Llera-Moya Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2011 127 135
14. J.D. Otvos, S. Mora, I. Shalaurova, P. Greenland, R.H. Mackey, D.C. Goff Clinical implications of discordance between low-density lipoprotein cholesterol and particle number J Clin Lipidol 5 2011 105 113
15. E.M. deGoma, R.L. deGoma, D.J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches J Am Coll Cardiol 51 2008 2199 2211
16. R.S. Rosenson, H.B. Brewer Jr., M.J. Chapman HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events Clin Chem 57 2011 392 410
17. J.M. Morgan, D.M. Capuzzi, R.I. Baksh Effects of extended-release niacin on lipoprotein subclass distribution Am J Cardiol 91 2003 1432 1436
18. W.E. Boden, J.L. Probstfield, T. Anderson Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267